Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia

Identification of Dysbetalipoproteinemia by an Enhanced Sampson-NIH Equation for Very Low-Density Lipoprotein-Cholesterol

(2022) Maureen Sampson et al.   Frontiers in Genetics

Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations

(2022) Maureen Sampson et al.   Biomedicines

Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson’s, Martin’s and Friedewald’s equations

(2021) Arsenio Vargas-Vázquez et al.   Lipids in Health and Disease

A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia

(2020) Maureen Sampson et al.   JAMA Cardiology

Pediatric dyslipidemia - beyond familial hypercholesterolemia

(2020) Julieta Lazarte et al.   CANADIAN JOURNAL OF CARDIOLOGY

The clinical and laboratory investigation of dysbetalipoproteinemia

(2020) Christopher S. Boot et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins

(2020) Mie Balling et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data from UK Biobank

(2019) Claire Welsh et al.   CIRCULATION

Apolipoprotein B Particles and Cardiovascular Disease

(2019) Allan D. Sniderman et al.   JAMA Cardiology

Performance of LDL-C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemia

(2018) Roopa Mehta et al.   ATHEROSCLEROSIS

PCSK9

(2018) Michael D. Shapiro et al.   CIRCULATION RESEARCH

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

(2018) Michel R. Langlois et al.   CLINICAL CHEMISTRY

Discordance between lipoprotein particle number and cholesterol content

(2018) Eric P. Cantey et al.   Current Opinion in Endocrinology Diabetes and Obesity

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

Reliability of Calculated Low-Density Lipoprotein Cholesterol

(2015) Jeffrey W. Meeusen et al.   AMERICAN JOURNAL OF CARDIOLOGY

Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia

(2015) Ivette Cruz-Bautista et al.   CLINICA CHIMICA ACTA

Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C

(2015) Michael J Pencina et al.   European Journal of Preventive Cardiology

Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB

(2014) Allan D. Sniderman et al.   CURRENT OPINION IN LIPIDOLOGY

Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events

(2013) Samia Mora et al.   CIRCULATION

Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile

(2013) Seth S. Martin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications

(2013) Seth S. Martin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY